Literature DB >> 24651468

Cognitive impairment in cocaine users is drug-induced but partially reversible: evidence from a longitudinal study.

Matthias Vonmoos1, Lea M Hulka1, Katrin H Preller1, Franziska Minder1, Markus R Baumgartner2, Boris B Quednow1.   

Abstract

Cocaine users consistently display cognitive impairments. However, it is still unknown whether these impairments are cocaine-induced and if they are reversible. Therefore, we examined the relation between changing intensity of cocaine use and the development of cognitive functioning within 1 year. The present data were collected as part of the longitudinal Zurich Cocaine Cognition Study (ZuCo(2)St). Forty-eight psychostimulant-naive controls and 57 cocaine users (19 with increased, 19 with decreased, and 19 with unchanged cocaine use) were eligible for analysis. At baseline and after a 1-year follow-up, cognitive performance was measured by a global cognitive index and four neuropsychological domains (attention, working memory, declarative memory, and executive functions), calculated from 13 parameters of a broad neuropsychological test battery. Intensity of cocaine use was objectively determined by quantitative 6-month hair toxicology at both test sessions. Substantially increased cocaine use within 1 year (mean +297%) was associated with reduced cognitive performance primarily in working memory. By contrast, decreased cocaine use (-72%) was linked to small cognitive improvements in all four domains. Importantly, users who ceased taking cocaine seemed to recover completely, attaining a cognitive performance level similar to that of the control group. However, recovery of working memory was correlated with age of onset of cocaine use-early-onset users showed hampered recovery. These longitudinal data suggest that cognitive impairment might be partially cocaine-induced but also reversible within 1 year, at least after moderate exposure. The reversibility indicates that neuroplastic adaptations underlie cognitive changes in cocaine users, which are potentially modifiable in psychotherapeutical or pharmacological interventions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24651468      PMCID: PMC4104339          DOI: 10.1038/npp.2014.71

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  44 in total

1.  Dose-related neurobehavioral effects of chronic cocaine use.

Authors:  K I Bolla; R Rothman; J L Cadet
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1999       Impact factor: 2.198

2.  Interpreting the color effect of melanin on cocaine and benzoylecgonine assays for hair analysis: brown and black samples compared.

Authors:  Tom Mieczkowski; Michael Kruger
Journal:  J Forensic Leg Med       Date:  2006-10-13       Impact factor: 1.614

3.  Neuropsychological assessment of current and past crack cocaine users.

Authors:  Lúcio Garcia De Oliveira; Lúcia Pereira Barroso; Camila Magalhães Silveira; Zila Van Der Meer Sanchez; Julio De Carvalho Ponce; Leonardo José Vaz; Solange Aparecida Nappo
Journal:  Subst Use Misuse       Date:  2009       Impact factor: 2.164

4.  Neurocognitive deficits in cocaine users: a quantitative review of the evidence.

Authors:  Diana Jovanovski; Suzanne Erb; Konstantine K Zakzanis
Journal:  J Clin Exp Neuropsychol       Date:  2005-02       Impact factor: 2.475

5.  Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence.

Authors:  Victoria Di Sclafani; Marina Tolou-Shams; Leonard J Price; George Fein
Journal:  Drug Alcohol Depend       Date:  2002-04-01       Impact factor: 4.492

6.  The validity and reliability of a brief measure of cocaine craving.

Authors:  Bradley D Sussner; David A Smelson; Stephanie Rodrigues; Anna Kline; Miklos Losonczy; Douglas Ziedonis
Journal:  Drug Alcohol Depend       Date:  2005-12-27       Impact factor: 4.492

Review 7.  Psychomotor and electroencephalographic sequelae of cocaine dependence.

Authors:  L O Bauer
Journal:  NIDA Res Monogr       Date:  1996

8.  Cognitive dysfunctions in recreational and dependent cocaine users: role of attention-deficit hyperactivity disorder, craving and early age at onset.

Authors:  Matthias Vonmoos; Lea M Hulka; Katrin H Preller; Daniela Jenni; Markus R Baumgartner; Rudolf Stohler; Karen I Bolla; Boris B Quednow
Journal:  Br J Psychiatry       Date:  2013-05-23       Impact factor: 9.319

9.  Recreational cocaine polydrug use impairs cognitive flexibility but not working memory.

Authors:  Lorenza S Colzato; Mariëtte Huizinga; Bernhard Hommel
Journal:  Psychopharmacology (Berl)       Date:  2009-09-02       Impact factor: 4.530

10.  Cocaine users manifest impaired prosodic and cross-modal emotion processing.

Authors:  Lea M Hulka; Katrin H Preller; Matthias Vonmoos; Sarah D Broicher; Boris B Quednow
Journal:  Front Psychiatry       Date:  2013-09-05       Impact factor: 4.157

View more
  36 in total

1.  Cognitive impairment in individuals with bipolar disorder with and without comorbid alcohol and/or cocaine use disorders.

Authors:  Chengxi Li; Jayme M Palka; E Sherwood Brown
Journal:  J Affect Disord       Date:  2020-04-29       Impact factor: 4.839

2.  The cognitive cost of reducing relapse to cocaine-seeking with mGlu5 allosteric modulators.

Authors:  Christina Gobin; Marek Schwendt
Journal:  Psychopharmacology (Berl)       Date:  2019-08-24       Impact factor: 4.530

Review 3.  The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.

Authors:  Vanessa Chilunda; Tina M Calderon; Pablo Martinez-Aguado; Joan W Berman
Journal:  Brain Res       Date:  2019-08-29       Impact factor: 3.252

4.  Reversal learning deficits in criminal offenders: Effects of psychopathy, substance use, and childhood maltreatment history.

Authors:  Monika Dargis; Richard C Wolf; Michael Koenigs
Journal:  J Psychopathol Behav Assess       Date:  2016-10-08

Review 5.  Cognitive dysfunction in individuals with cocaine use disorder: Potential moderating factors and pharmacological treatments.

Authors:  James J Mahoney
Journal:  Exp Clin Psychopharmacol       Date:  2018-12-17       Impact factor: 3.157

6.  Effects of cocaine base paste on anxiety-like behavior and immediate-early gene expression in nucleus accumbens and medial prefrontal cortex of female mice.

Authors:  Bruno G Berardino; Estefanía A Fesser; Laura M Belluscio; Octavio Gianatiempo; Nicolás Pregi; Eduardo T Cánepa
Journal:  Psychopharmacology (Berl)       Date:  2019-07-06       Impact factor: 4.530

7.  An Exploratory Factor Analysis of a Brief Self-Report Scale to Detect Neurocognitive Impairment Among Participants Enrolled in Methadone Maintenance Therapy.

Authors:  Michael Copenhaver; Roman Shrestha; Jeffrey A Wickersham; Damian Weikum; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2016-01-13

8.  Long-Term Blockade of Cocaine Self-Administration and Locomotor Activation in Rats by an Adenoviral Vector-Delivered Cocaine Hydrolase.

Authors:  John R Smethells; Natashia Swalve; Stephen Brimijoin; Yang Gao; Robin J Parks; Adam Greer; Marilyn E Carroll
Journal:  J Pharmacol Exp Ther       Date:  2016-03-11       Impact factor: 4.030

9.  Prefrontal gray matter volume recovery in treatment-seeking cocaine-addicted individuals: a longitudinal study.

Authors:  Muhammad A Parvaz; Scott J Moeller; Federico d'Oleire Uquillas; Amanda Pflumm; Tom Maloney; Nelly Alia-Klein; Rita Z Goldstein
Journal:  Addict Biol       Date:  2016-04-28       Impact factor: 4.280

Review 10.  Adolescent-onset vs. adult-onset cocaine use: Impact on cognitive functioning in animal models and opportunities for translation.

Authors:  Kathleen M Kantak
Journal:  Pharmacol Biochem Behav       Date:  2020-07-11       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.